LEADER 05170nam 22006734a 450 001 9910961672103321 005 20251017110113.0 010 $a0-309-17250-0 010 $a0-309-66390-3 010 $a0-309-51608-0 035 $a(CKB)110986584752892 035 $a(EBL)3375288 035 $a(SSID)ssj0000252232 035 $a(PQKBManifestationID)11191551 035 $a(PQKBTitleCode)TC0000252232 035 $a(PQKBWorkID)10175799 035 $a(PQKB)11087965 035 $a(MiAaPQ)EBC3375288 035 $a(Au-PeEL)EBL3375288 035 $a(CaPaEBR)ebr10038558 035 $a(OCoLC)923254958 035 $a(DNLM)929558 035 $a(BIP)53854121 035 $a(BIP)6397742 035 $a(EXLCZ)99110986584752892 100 $a20000915d1999 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aStrategies to protect the health of deployed U.S. forces $eforce protection and decontamination /$fMichael A. Wartell ... [et al.] 210 $aWashington, D.C. $cNational Academy Press$dc1999 215 $a1 online resource (262 p.) 225 1 $aThe compass series 300 $aDescription based upon print version of record. 311 1 $a0-309-06793-6 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Tables, Figures, and Box""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Threat and Risk Assessment""; ""3 Philosophy, Doctrine, and Training for Chemical and Biological Warfare""; ""4 Physical Protection""; ""5 Decontamination""; ""6 Testing and Evaluation""; ""7 Assessment of Military Capabilities to Provide Emergency Response""; ""8 Summary and General Recommendations""; ""References"" 327 $a""Appendix A Funding Levels for Fiscal Years 1996-2000 for the Joint Service Chemical/Biological Defense Program"" ""Appendix B Textiles and Garments for Chemical and Biological Protection""; ""Appendix C Evaluations of Barrier Creams""; ""Appendix D Evaluating Skin Decontamination Techniques""; ""Appendix E Percutaneous Absorption""; ""Appendix F Contributors to This Study""; ""Appendix G Biographical Sketches of Principal Investigators and Members of the Advisory Panel"" 330 $aSince Operation Desert Shield/Desert Storm, Gulf War veterans have expressed concerns that their postdeployment medical symptoms could have been caused by hazardous exposures or other deployment-related factors. Potential exposure to a broad range of CB and other harmful agents was not unique to Gulf operations. Hazardous exposures have been a component of all military operations in this century. Nevertheless, the Gulf War deployment focused national attention on the potential, but uncertain, relationship between the presence of CB agents in theater and symptoms reported by military personnel. Particular attention has been given to the potential long-term health effects of low-level exposures to CB agents. In the spring of 1996, Deputy Secretary of Defense John White met with the leadership of the National Academies to discuss the DoD's continuing efforts to improve protection of military personnel from adverse health effects during deployments in hostile environments. Although many lessons learned from previous assessments of Operation Desert Shield/Desert Storm have been reported, prospective analyses are still needed. Strategies to Protect the Health of Deployed U.S. Forces: Force Protection and Decontamination, which addresses the issues of physical protection and decontamination, is one of four initial reports that will be submitted in response to that request. Specifically, this report includes a review and evaluation of the following areas: the adequacy of current protective equipment and protective measures (as well as equipment in development) the efficacy of current and proposed methods for decontaminating personnel and equipment after exposures to CB agents current policies, doctrine, and training to protect and decontaminate personnel and equipment in future deployments (i.e., major regional conflicts [MRCs], lesser regional conflicts [LRCs], and operations other than war [OOTWs]) the impact of equipment and procedures on unit effectiveness and other human performance factors current and projected military capabilities to provide emergency response 410 0$aCompass series (Washington, D.C.) 606 $aChemical weapons$xSafety measures 606 $aBiological weapons$xSafety measures 606 $aMilitary planning$zUnited States 607 $aUnited States$xArmed Forces$xMedical care 607 $aUnited States$xArmed Forces$xSanitary affairs 615 0$aChemical weapons$xSafety measures. 615 0$aBiological weapons$xSafety measures. 615 0$aMilitary planning 676 $a358/.3 701 $aWartell$b Michael A$01202021 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910961672103321 996 $aStrategies to protect the health of deployed U.S. forces$94447547 997 $aUNINA